Filing Flows › Bionano Genomics (BNGO) › R&D spending
Bionano Genomics (BNGO) R&D spending by quarter
Bionano Genomics' R&D spending was $3.0M in Q2 2026 (second quarter 2026), -5% from Q1 2026. Over the last 7 quarters it ranged from $2.4M (Q1 2025) to $3.5M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.0M | -5% | +2% |
| Q1 2026 | $3.1M | -3% | +32% |
| Q4 2025 | $3.2M | +14% | -7% |
| Q3 2025 | $2.8M | -3% | — |
| Q2 2025 | $2.9M | +24% | — |
| Q1 2025 | $2.4M | -32% | — |
| Q4 2024 | $3.5M | — | — |
Q2 2026 at a glance
Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bionano Genomics' R&D spending?
Bionano Genomics' R&D spending was $3.0M in Q2 2026 (second quarter 2026), -5% from Q1 2026.
How has Bionano Genomics' R&D spending changed?
Over the last 7 quarters it ranged from $2.4M (Q1 2025) to $3.5M (Q4 2024).